MedPacto gets FDA OK for colorectal cancer drug clinical trial

MedPacto gets FDA OK for colorectal cancer drug clinical trial

South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...

MedPacto's anti-cancer substance designated as US FDA fast-track item

MedPacto's anti-cancer substance designated as US FDA fast-track item

South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner